Lipoprotein X as a source of analytical and interpretative interference in routine laboratory testing

Area of Science:

• Clinical Chemistry
• Lipid Metabolism
• Diagnostic Laboratory Science

Background:

• Lipoprotein X (LpX) is an abnormal particle found in cholestasis and other conditions.
• Its unique composition challenges standard laboratory lipid testing methods.
• LpX can cause analytical interference and interpretative distortion in cholesterol measurements.

Purpose of the Study:

• To review the analytical and interpretative challenges posed by LpX in laboratory testing.
• To propose screening triggers and confirmation methods for LpX detection.
• To discuss the clinical implications and potential atherogenicity of LpX.

Main Methods:

• Review of existing literature on LpX.
• Analysis of LpX interference with common lipid measurement assays.
• Proposal of screening criteria based on total cholesterol and apolipoprotein B (apoB) levels.
• Discussion of confirmatory diagnostic techniques including electrophoresis, NMR, and lipidomics.

Main Results:

• Standard calculated and direct LDL-cholesterol assays may inaccurately quantify cholesterol in the presence of LpX.
• Proposed screening triggers include high total cholesterol and specific ratios of total cholesterol/apoB or non-HDL-C/apoB.
• Confirmatory methods provide definitive LpX identification.

Conclusions:

• A structured laboratory workflow for LpX detection is crucial for accurate dyslipidemia assessment.
• Identifying LpX prevents misclassification of lipid disorders and pseudoelectrolyte abnormalities.
• While potentially less atherogenic than LDL, LpX is associated with clinical complications and requires careful management.